# A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure

> **NCT06692764** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 202 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Placebo
- **DRUG:** AZD0780

## Key facts

- **NCT ID:** NCT06692764
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-30
- **Primary completion:** 2025-04-18
- **Final completion:** 2025-05-02
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06692764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06692764, "A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06692764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*